TRICIUM PTH PEN INJECTION

Tricium PTH Pen injection is a source of the active component known as Teriparatide. It is a Tricium-PTH pen injection, an artificial version of the Parathyroid Hormone (PTH) made by parathyroid glands and used to treat osteoporosis. Osteoporosis is a disease characterized by weak bones, increasing the risk of breaking. Osteoporosis-related fractures can significantly impact a person’s well-being, which can cause pain and limit mobility. Tricium PTH Pen injections promote the development of new bone tissue and increase bone density. The drug has been demonstrated to speed up the healing process of bone in patients suffering from fractures. It encourages the development of callus, the bridge of bone that develops in the healing process, leading to faster and better healing.
People who are known to have allergy or hypersensitivity to Tricium PTH Pen injection or any of its components are advised to avoid this drug. It is not recommended for people who have any history of malignancies of the skeleton, like osteosarcoma, or patients who have bone metastases. If a patient has had previous radiation therapy that involved the skeleton, usage of this drug is not recommended due to the risk of developing osteosarcoma.